Velvette International Pharma Products Ltd - Stock Valuation and Financial Performance

BSE: 524528 | NSE: | Household & Personal Products | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Velvette Intl. Phar

M-Cap below 100cr DeciZen not available

Velvette International Pharma Products stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
1.5 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Velvette Intl. Phar:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
ROCE % 5.4%5.8%8.5%4.3%-98.7%-4.6%-12.8%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 856.15.345.10.91
Sales YoY Gr.--37.5%22.2%-13.7%-24.8%29%-82%-
Adj EPS -2.4-0.80.10-27-0.6-1.5-1.5
YoY Gr.-NANA-20%-67675%NANA-
BVPS (₹) 8.48.69.210.4-15.5-10.3-10.9-9.4
Adj Net
Profit
-0.9-0.300-10.1-0.3-0.8-1
Cash Flow from Ops. -0.1-0.3-0.7-0.2-0.2-0.30.1-
Debt/CF from Ops. -203-33.6-16.2-63-53.2-32.874.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-28.8%-44.2%-82%
Adj EPS NANA-437.7%NA
BVPSNA-205%-201.7%NA
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
Return on
Equity %
-14.2-4.70.30.3-930.87.116.815.1
Op. Profit
Mgn %
9.517.920.89.7-241.7-3.1-72.716.9
Net Profit
Mgn %
-11.1-5.80.30.3-254-5.6-82.3-82.5
Debt to
Equity
33.13.12.8-1.9-2.1-2-
Working Cap
Days
01,0367879569224482,5740
Cash Conv.
Cycle
0301478644544772880

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Velvette International Pharma Products Ltd.

Standalone Consolidated
TTM EPS (₹) -1.5 -
TTM Sales (₹ Cr.) 0.9 -
BVPS (₹.) -9.4 -
Reserves (₹ Cr.) -9 -
P/BV -0.33 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 0.64 / 8.25
Market Cap (₹ Cr.) 1.5
Equity (₹ Cr.) 4.9
Face Value (₹) 10
Industry PE 60.1

Management X-Ray of Velvette Intl. Phar:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Velvette Intl. Phar

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Sales8.025.016.125.283.975.120.92
Operating Expenses 7.264.114.854.7713.575.281.59
Manufacturing Costs0.090.050.050.060.100.110.04
Material Costs3.902.352.722.801.911.890.45
Employee Cost 0.600.360.390.340.470.540.13
Other Costs 2.661.351.691.5811.102.740.97
Operating Profit 0.760.891.270.51-9.60-0.16-0.67
Operating Profit Margin (%) 9.5%17.9%20.8%9.7%-241.0%-3.1%-72.7%
Other Income 0.080.020.040.240.070.040.07
Interest 1.571.031.140.480.430.040.04
Depreciation 0.160.180.150.140.120.130.11
Exceptional Items 0000000
Profit Before Tax -0.89-0.290.020.14-10.09-0.29-0.76
Tax 0000.02000
Profit After Tax -0.89-0.290.020.11-10.09-0.29-0.76
PAT Margin (%) -11.1%-5.8%0.4%2.2%-253.0%-5.6%-82.3%
Adjusted EPS (₹)-2.4-0.80.10.3-27.0-0.6-1.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05

Equity and Liabilities

Shareholders Fund 6.2966.026.13-3.96-4.14-4.90
Share Capital 3.733.733.733.733.734.934.93
Reserves 2.552.262.292.39-7.69-9.08-9.83
Minority Interest0000000
Debt9.469.8910.7010.6510.8110.8810.74
Long Term Debt9.469.8910.7010.6510.8110.8810.74
Short Term Debt0000000
Trade Payables5.242.071.431.561.391.681.70
Others Liabilities 0.090.120.040.151.330.910.84
Total Liabilities 21.0818.0818.1918.479.579.338.37

Fixed Assets

Gross Block3.543.543.543.503.563.723.72
Accumulated Depreciation1.391.571.721.851.972.252.36
Net Fixed Assets2.141.971.821.651.591.471.35
CWIP 0000000
Investments 0.130.130.130.130.130.130.13
Inventories0.550.070.030.240.720.160.14
Trade Receivables10.6810.7111.0711.392.502.472.03
Cash Equivalents 0.170.250.190.260.160.110.11
Others Assets7.414.964.944.804.484.994.61
Total Assets 21.0818.0818.1918.479.579.338.37

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Cash Flow From Operating Activity -0.05-0.29-0.66-0.17-0.20-0.330.14
PBT -0.89-0.290.020.14-10.09-0.29-0.76
Adjustment 2.141.611.720.919.510.700.68
Changes in Working Capital 0.28-0.59-1.26-0.740.8-0.70.26
Tax Paid 0000000
Cash Flow From Investing Activity -1.34-0.06-0.200.05-0.062.100
Capex 0000.17-0.062.100
Net Investments 0000000
Others -1.33-0.06-0.20-0.11000
Cash Flow From Financing Activity 1.250.430.810.180.16-1.83-0.14
Net Proceeds from Shares 0000000
Net Proceeds from Borrowing 0000000
Interest Paid 0000000
Dividend Paid 0000000
Others 1.250.430.810.180.16-1.83-0.14
Net Cash Flow -0.130.08-0.060.07-0.10-0.060
PARTICULARSMar'98Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Ratios
ROE (%)-28.48-9.20.663.1N/AN/AN/A
ROCE (%)5.415.768.514.28N/AN/AN/A
Asset Turnover Ratio0.380.260.340.290.280.540.1
PAT to CFO Conversion(x)N/AN/A-33-1.55N/AN/AN/A
Working Capital Days
Receivable Days486779649776638177893
Inventory Days2523310443160
Payable Days4905672351952802961,373

Velvette International Pharma Products Ltd Stock News

Velvette International Pharma Products Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Velvette Intl. Phar on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Velvette Intl. Phar stood at ₹1.53.
The latest P/E ratio of Velvette Intl. Phar as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Velvette Intl. Phar as of 01-Jan-1970 05:30 is -0.33.
The 52-week high of Velvette Intl. Phar is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Velvette Intl. Phar is ₹0.92 ( Cr.) .

About Velvette International Pharma Products Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.